Baxter International

Baxter International develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operates through three segments: BioScience, Medication Delivery, and Renal. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Company Growth (employees)
Type
Public
HQ
Deerfield, US
Founded
1931
Size (employees)
48,000 (est)
Website
baxter.com
Baxter International was founded in 1931 and is headquartered in Deerfield, US

Key People/Management at Baxter International

José Almeida

José Almeida

Chairman, President and Chief Executive Officer
Paul Martin

Paul Martin

VP & CIO
James Saccaro

James Saccaro

CVP
Andrew Frye

Andrew Frye

Senior Vice President and President, APAC
Jeanne Mason

Jeanne Mason

CVP of HR

Baxter International Office Locations

Baxter International has offices in Deerfield, Ho Chi Minh City, Minneapolis, Newbury and in 35 other locations
Deerfield, US (HQ)
One Baxter Parkway
Show all (39)

Baxter International Financials and Metrics

Baxter International Financials

Baxter International's revenue was reported to be $10.2 b in FY, 2016
USD

Revenue (Q2, 2017)

2.6 b

Gross profit (Q2, 2017)

1.1 b

Gross profit margin (Q2, 2017), %

43%

Net income (Q2, 2017)

265 m

EBIT (Q2, 2017)

339 m

Market capitalization (13-Nov-2017)

35.9 b

Cash (30-Jun-2017)

3.8 b
Baxter International's current market capitalization is $35.9 b.
USDFY, 2015FY, 2016

Revenue

10 b10.2 b

Revenue growth, %

(40%)2%

Cost of goods sold

5.8 b6.1 b

Gross profit

4.1 b4.1 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

3.8 b4 b4.3 b4.2 b3.8 b3.9 b2.5 b2.4 b2.6 b2.6 b2.5 b2.6 b

Cost of goods sold

1.8 b2 b2.2 b2.1 b2 b2 b1.5 b1.4 b1.6 b1.5 b1.4 b1.5 b

Gross profit

1.9 b2 b2 b2.1 b1.8 b1.9 b1 b965 m972 m1.1 b1 b1.1 b

Gross profit Margin, %

52%50%48%49%48%49%42%41%38%42%42%43%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

2.7 b2.9 b2.2 b2.8 b

Inventories

3.5 b3.6 b1.6 b1.4 b

Current Assets

10 b10.4 b11.8 b6.6 b

PP&E

7.8 b8.7 b4.4 b4.3 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

2.4 b2 b1.9 b2.1 b2.5 b6.7 b2 b2.2 b2.6 b2.6 b2.9 b3.8 b

Inventories

3.6 b3.7 b3.8 b3.7 b3.5 b3.8 b1.7 b1.7 b1.6 b1.6 b1.5 b1.5 b

Current Assets

9.6 b9.4 b9.5 b9.6 b9.7 b14.5 b11.1 b8 b6.8 b6.6 b6.6 b7.7 b

PP&E

7.5 b8 b8.2 b8.4 b8.5 b9 b4.3 b4.4 b4.3 b4.3 b4.3 b4.3 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2 b2.5 b968 m5 b

Inventories

(311 m)(439 m)1.6 b80 m

Cash From Operating Activities

2.2 b3.2 b1.8 b1.7 b

Capital Expenditures

(1.5 b)(1.9 b)(911)(719 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

544 m556 m520 m468 m430 m762 m763 m3.4 b4.6 b4.7 b272 m537 m

Depreciation and Amortization

497 m593 m189 m395 m599 m194 m378 m

Inventories

(439 m)(205 m)(26 m)(25 m)(11 m)(29 m)(38 m)

Capital Expenditures

(1 b)(658 m)(184 m)(352 m)(519 m)(123 m)(279 m)
USDY, 2017

Revenue/Employee

54.3 k

Financial Leverage

1.9 x
Show all financial metrics

Baxter International Market Value History

Baxter International's Web-traffic and Trends

Baxter International Online and Social Media Presence

Baxter International Company Life and Culture

You may also be interested in